NCT01081548已完成4 期
A Multi-center, Randomized, Open-labeled Clinical Trial to Evaluate Efficacy and Safety of Lipinon® 20mg Versus Lipitor® 20mg in Korean Patients With Hypercholesterolemia
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 17
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to compare the efficacy and safety of atorvastatin generic product with reference drug.
研究设计
- 研究类型
- Interventional
- 干预模型
- Parallel
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 20 ~ 79
- •People who have not reached LDL-C targeted level in accordance with the guidelines for hyperlipidemia management released by Korean Society of Lipidology and Atherosclerosis
- •In case of female participants taking combination HRT or oral contraceptive, they should maintain stable capacity and usage at least for 8 weeks before the visit 1.
排除标准
- 未提供
研究组 & 干预措施
Generic
Experimental
干预措施: atorvastatin (Drug)
Lipitor
Active Comparator
干预措施: atorvastatin (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mgHypercholesterolemiaNCT01624207Seoul National University Hospital376
已完成
3 期
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin TherapyHypercholesteremiaNCT00239330AstraZeneca824
已完成
4 期
Comparative Atorvastatin Pleiotropic EffectsCoronary ArteriosclerosisHypercholesterolemiaNCT00163202Pfizer's Upjohn has merged with Mylan to form Viatris Inc.330
已完成
2 期
Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)Type 1 DiabetesNCT00529191Children's Hospital of Philadelphia40
已完成
4 期
A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High CholesterolHyperlipidemiasNCT00645424Pfizer's Upjohn has merged with Mylan to form Viatris Inc.155